Sugentech Inc.
Financials
Valuation Metrics
Sugentech Inc.'s Market Cap is ₩702B. At end of 2025 it was ₩1028B. Ranked #1487 of 2,436 in KR market (top 61%), #852 of 1,649 on KOSDAQ (top 52%), #55 of 96 in Health Care Equipment & Services (top 57%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 70.15B KRW | KR#1,487/2,436 Sec#55/96 |
| Revenue | 9.87B KRW | KR#2,289/2,436 Sec#82/96 |
| Net Income | -24.65B KRW | KR—/2,436 Sec—/96 |
| Total Assets | 93.72B KRW | KR#1,795/2,436 Sec#53/96 |
| Net Assets | 72.28B KRW | KR#1,627/2,436 Sec#51/96 |
| Employees | 152 | KR#1,314/2,436 Sec#44/96 |
| Value | ||
| P/B | 0.97x | KR#1,466/2,436 Sec#38/96 |
| P/S | 7.11x | KR#2,214/2,436 Sec#77/96 |
| Profitability | ||
| ROE | -34.11% | KR#2,198/2,436 Sec#80/96 |
| ROA | -26.30% | KR#2,267/2,436 Sec#84/96 |
| Op. Margin | -197.83% | KR#2,339/2,436 Sec#89/96 |
| Revenue Growth | 24.18% | KR#569/2,436 Sec#24/96 |
| Financial Health | ||
| Debt Ratio | 129.67% | KR#847/2,436 Sec#38/96 |
| Total Debt | 11.23B KRW | KR#1,579/2,436 Sec#49/96 |
| Cash | 20.16B KRW | KR#1,231/2,436 Sec#32/96 |
| Current Ratio | 10.82x | KR#88/2,436 Sec#10/96 |
| Performance | ||
| 1Y Return | -40.99% | KR#1,859/2,436 Sec#66/96 |
| 1M Return | 10.85% | KR#262/2,436 Sec#17/96 |
| From 52W High | -51.67% | KR#1,275/2,436 Sec#49/96 |
| 1Y MDD | -53.94% | KR#1,105/2,436 Sec#39/96 |
| Trading | ||
| Volume | 139,374 shares | KR#754/2,436 Sec#30/96 |
| Foreign Own. | 1.14% | KR—/2,436 Sec—/96 |
| Per Share | ||
| EPS | -1,461 KRW | KR—/2,436 Sec—/96 |
| BPS | 4,713 KRW | KR#1,485/2,436 Sec#39/96 |
Company Info
Established in 2011, the company achieved KONEX listing in 2016 and KOSDAQ transfer listing in 2019, with its main business being the research and development, manufacturing, and sales of in vitro diagnostic medical devices. It commercializes multiple immunoassay blots based on BIO/NANO/IT/A.I fusion technology and offers TRF and fluorescence-based quantitative analysis products for point-of-care diagnostics. In digital healthcare, Sugentech launched the nation's sole digital device for female hormone diagnosis, expanding into the health & beauty category to evolve into a comprehensive wellness platform. Sugentech is headquartered in Yuseong-gu, Daejeon Metropolitan City.